KYVERNA THERAPEUTICS INC

Ticker: KYTX CUSIP: 501976104 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 135,600 Value ($000) $1,275 Avg Close $7.42 Range $5.30 - $13.67

Q2 2025

Shares 62,057 Value ($000) $191 Avg Close $2.47 Range $1.78 - $3.82

Q1 2025

Shares 24,561 Value ($000) $47 Avg Close $2.95 Range $1.90 - $4.26

Q4 2024

Shares 15,241 Value ($000) $57 Avg Close $4.79 Range $3.54 - $7.20

Q3 2024

Shares 32,223 Value ($000) $158 Avg Close $7.71 Range $4.79 - $11.40

Q2 2024

Shares 10,400 Value ($000) $78 Avg Close $15.28 Range $6.75 - $25.84

Q1 2024

Shares 155,755 Value ($000) $3,869 Avg Close $27.84 Range $23.12 - $30.60

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	135,600	$1,275	$7.42	$5.30 - $13.67
Q2 2025	62,057	$191	$2.47	$1.78 - $3.82
Q1 2025	24,561	$47	$2.95	$1.90 - $4.26
Q4 2024	15,241	$57	$4.79	$3.54 - $7.20
Q3 2024	32,223	$158	$7.71	$4.79 - $11.40
Q2 2024	10,400	$78	$15.28	$6.75 - $25.84
Q1 2024	155,755	$3,869	$27.84	$23.12 - $30.60